SEC Form 4 · accession 0000904454-16-001423
MusclePharm Corp · MSLP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William John Bush
Director
Period of report
Jul 16, 2016
Accepted (ET)
Sep 2, 2016 · 11:58 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001415684
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 16, 2016 | A | 64,338 | $0.00 | A | 90,529 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares of restricted stock awarded under the Issuer's 2015 Equity Incentive Compensation Plan, vesting as follows: 16,084 shares on 10/17/2016; 16,084 shares on 01/16/2017; 16,085 shares on 04/17/2017; and 16,085 shares on 07/18/2017.